Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...
Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...
MedPage Today on MSN
Medicare Decision on GLP-1s Soon; Inhaled Insulin Under Review for Kids; 'Manopause'
Rapid-acting inhaled insulin (Afrezza) is under FDA review for children ages 4 to 17 with diabetes, said maker MannKind. If ...
In the end, people taking GLP-1 drugs consistently reported feeling less intoxicated, the study found. Data taken during the ...
Explore how functional ingredients are challenging GLP-1 drugs in weight management – and what this shift means for food and ...
Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...
Coshocton Tribune on MSN
What you need to know about GLP-1 and how it helps manage blood sugar levels naturally
When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...
Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials.
Zacks.com on MSN
LLY's Oral GLP-1 Pill Scores Another Pair of Diabetes Wins
Eli Lilly's oral GLP-1 pill orforglipron delivers strong A1C reductions in two late-stage diabetes studies, reinforcing its ...
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking ...
Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback